{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-012883","form_type":"8-K","ticker":"CYCU","cik":"0001868419","company_name":"Cycurion, Inc.","filed_at":"2026-02-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.616906+00:00","generated_at":"2026-05-15T23:11:59.611076+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Cycurion adjourns special meeting to March 19; needs quorum for warrant share issuance","bullets":["Special meeting adjourned from Feb 26 to March 19, 2026 due to insufficient votes to reach quorum.","Meeting seeks approval for up to 3,314,920 common shares on exercise of warrants from Dec 2025 private placement, potentially >20% of outstanding stock.","Record date remains Jan 21, 2026; previously submitted proxies remain valid unless revoked.","Stockholders who haven't voted are encouraged to vote; instructions in definitive proxy statement filed Feb 2, 2026.","Company engaged D.F. King & Co. as proxy solicitor."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-012883","json":"https://secwatch.observer/filing/0001628280-26-012883.json","markdown":"https://secwatch.observer/filing/0001628280-26-012883.md","text":"https://secwatch.observer/filing/0001628280-26-012883.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1868419/000162828026012883/0001628280-26-012883-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1868419/000162828026012883/cycu-20260226.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T23:11:59.611076+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"comparable_filings":[{"accession":"0001437749-26-019196","ticker":"NRXP","company_name":"NRX Pharmaceuticals, Inc.","filed_at":"2026-06-02T21:30:08+00:00","headline":"NRx Pharmaceuticals proposes public offering of common stock; terms not set","event_type":"other_material","sec_items":["8.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-019196","json":"https://secwatch.observer/filing/0001437749-26-019196.json","markdown":"https://secwatch.observer/filing/0001437749-26-019196.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1719406/000143774926019196/0001437749-26-019196-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1719406/000143774926019196/nrxp20260602_8k.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-253795","ticker":"AVA","company_name":"AVISTA CORP","filed_at":"2026-06-02T21:02:55+00:00","headline":"Avista signs non-binding MOU for 125 MW load, expandable to 500 MW by 2032","event_type":"other_material","sec_items":["8.01","9.01"],"materiality_score":0.4,"calibrated_materiality_score":0.4,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-253795","json":"https://secwatch.observer/filing/0001193125-26-253795.json","markdown":"https://secwatch.observer/filing/0001193125-26-253795.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/104918/000119312526253795/0001193125-26-253795-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/104918/000119312526253795/ava-20260529.htm"},"side_by_side_evidence":null},{"accession":"0001628280-26-039818","ticker":"ARVN","company_name":"ARVINAS, INC.","filed_at":"2026-06-02T20:39:40+00:00","headline":"Arvinas to out-license ARV-806 after completing Phase 1 dose escalation","event_type":"other_material","sec_items":["7.01","8.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-039818","json":"https://secwatch.observer/filing/0001628280-26-039818.json","markdown":"https://secwatch.observer/filing/0001628280-26-039818.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1655759/000162828026039818/0001628280-26-039818-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1655759/000162828026039818/arvn-20260602.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-253506","ticker":"JAGX","company_name":"Jaguar Health, Inc.","filed_at":"2026-06-02T20:10:13+00:00","headline":"Jaguar Health issues 64,668 common shares for Series Q Preferred; annual meeting adjourned to June 8","event_type":"other_material","sec_items":["1.01","3.02","8.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-253506","json":"https://secwatch.observer/filing/0001193125-26-253506.json","markdown":"https://secwatch.observer/filing/0001193125-26-253506.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1585608/000119312526253506/0001193125-26-253506-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1585608/000119312526253506/d95782d8k.htm"},"side_by_side_evidence":null},{"accession":"0001493152-26-026866","ticker":"OTAI","company_name":"Starlink AI Acquisition Corp","filed_at":"2026-06-02T20:05:25+00:00","headline":"Starlink AI Acquisition closes partial over-allotment, adds $5M to trust","event_type":"other_material","sec_items":["3.02","8.01","9.01"],"materiality_score":0.4,"calibrated_materiality_score":0.4,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-026866","json":"https://secwatch.observer/filing/0001493152-26-026866.json","markdown":"https://secwatch.observer/filing/0001493152-26-026866.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2094076/000149315226026866/0001493152-26-026866-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2094076/000149315226026866/form8-k.htm"},"side_by_side_evidence":null},{"accession":"0000089439-26-000025","ticker":"MLI","company_name":"MUELLER INDUSTRIES INC","filed_at":"2026-06-02T14:47:05+00:00","headline":"Mueller Industries announces 2-for-1 stock split; record date June 25, 2026","event_type":"other_material","sec_items":["8.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000089439-26-000025","json":"https://secwatch.observer/filing/0000089439-26-000025.json","markdown":"https://secwatch.observer/filing/0000089439-26-000025.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/89439/000008943926000025/0000089439-26-000025-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/89439/000008943926000025/mli-20260602.htm"},"side_by_side_evidence":null},{"accession":"0001104659-26-069251","ticker":"SLS","company_name":"SELLAS Life Sciences Group, Inc.","filed_at":"2026-06-02T12:30:40+00:00","headline":"SELLAS Life Sciences raised $28.7M from warrant exercises in Apr-May 2026","event_type":"other_material","sec_items":["8.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-069251","json":"https://secwatch.observer/filing/0001104659-26-069251.json","markdown":"https://secwatch.observer/filing/0001104659-26-069251.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1390478/000110465926069251/0001104659-26-069251-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1390478/000110465926069251/tm2616601d1_8k.htm"},"side_by_side_evidence":null},{"accession":"0001493152-26-026769","ticker":"MBOT","company_name":"Microbot Medical Inc.","filed_at":"2026-06-02T12:30:26+00:00","headline":"Microbot Medical secures first North Carolina customer for LIBERTY robotic system","event_type":"other_material","sec_items":["7.01","8.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-026769","json":"https://secwatch.observer/filing/0001493152-26-026769.json","markdown":"https://secwatch.observer/filing/0001493152-26-026769.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/883975/000149315226026769/0001493152-26-026769-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/883975/000149315226026769/form8-k.htm"},"side_by_side_evidence":null}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}